MedPath

Evaluation of Tetrix Cream as a Protective Barrier Against Injurious Materials

Not Applicable
Completed
Conditions
Healthy
Interventions
Device: Tetrix
Registration Number
NCT00643630
Lead Sponsor
Coria Laboratories, Ltd.
Brief Summary

To determine if Tetrix Cream,, when applied to the skin, acts as a barrier to prevent injury to the skin

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
36
Inclusion Criteria
  • Normal subjects who are sensitized to nickel, neomycin, or fragrance mix.
Exclusion Criteria
  • Under 18 years of age.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
1TetrixTwice daily topical application
2TetrixTwice daily topical application
Primary Outcome Measures
NameTimeMethod
Prevention of delayed bype hypersensitivity reaction following application of antigenup to 96 hours after antigen application
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Dermatolgoy Specialists, LLC

🇺🇸

Louisville, Kentucky, United States

© Copyright 2025. All Rights Reserved by MedPath